Moreover, Sal significantly reduced CHOP expression in cisplatin-induced injury in HEI-OC1 cells and cochleae, suggesting that Sal could also regulate the eIF2α-CHOP pathway to inhibit cisplatin-induced ERS in HCs. This evidence concerns the gene DDIT3 and amelogenesis imperfecta type 1G.